AI Image
FDA Announces New Nationwide Blood Pressure Medication Recall
AOL.com • • business
Key Points:
- Inventia Healthcare has issued a Class II recall for certain lots of chlorthalidone tablets, a medication used to treat high blood pressure, due to "failed dissolution specifications" which may reduce the drug's effectiveness.
- The recall includes over 13,000 bottles from a specific lot (Batch# RISA24002) of 25 mg chlorthalidone tablets with an expiration date of April 2027.
- A Class II recall indicates that exposure to the affected medication may cause temporary or medically reversible health issues, but serious effects are unlikely.
- Patients with the recalled medication should check their prescription labels carefully and contact their healthcare provider before making any changes to their medication regimen.
- If any symptoms or health concerns arise while using the recalled medication, individuals are advised to inform their doctor immediately.
